Pulmonx (LUNG) Amortization of Deferred Charges (2019 - 2025)

Pulmonx (LUNG) has 7 years of Amortization of Deferred Charges data on file, last reported at $100000.0 in Q3 2025.

• On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $100000.0 in Q3 2025; TTM through Sep 2025 was -$1.2 million, a 19.08% decrease from a year earlier, with the FY2024 full-year figure at $52000.0, up 8.33% from the prior year.
• Amortization of Deferred Charges for Q3 2025 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for LUNG reached as high as $701000.0 in Q1 2024 and fell as low as -$1.9 million in Q4 2023.
• Historically, Amortization of Deferred Charges has averaged -$23157.9 across 5 years, with a median of $100000.0 in 2021.
• Across the five-year window, Amortization of Deferred Charges tumbled 405.01% in 2023 and soared 6910.0% in 2024, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $17000.0 in 2021, then soared by 3658.82% to $639000.0 in 2022, then tumbled by 405.01% to -$1.9 million in 2023, then advanced by 25.14% to -$1.5 million in 2024, then jumped by 106.85% to $100000.0 in 2025.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $100000.0 in Q3 2025, $100000.0 in Q2 2025, and $11000.0 in Q1 2025.